Comparison
2q13 Microdeletion Syndrome C6012360 vs 14q12 Microdeletion Syndrome C4305240
Clinical comparison between 2q13 Microdeletion Syndrome and 14q12 Microdeletion Syndrome for differential diagnosis and treatment planning.
2q13 Microdeletion Syndrome C6012360
A rare genetic condition where a small piece of chromosome 2 is missing. It can affect development and cause distinctive features. Care involves multiple specialists based on symptoms.
14q12 Microdeletion Syndrome C4305240
A rare chromosomal condition where a segment of chromosome 14 is missing. It may cause developmental delays and other health concerns. Treatment is supportive and individualized.
6 comparison axes
Onset
2q13 Microdeletion Syndrome C6012360
Variable
14q12 Microdeletion Syndrome C4305240
0-1
Onset patterns differ
Severity
2q13 Microdeletion Syndrome C6012360
severe
14q12 Microdeletion Syndrome C4305240
moderate
Different severity levels
Chronic
2q13 Microdeletion Syndrome C6012360
Chronic
14q12 Microdeletion Syndrome C4305240
Chronic
Differing course
Communicable
2q13 Microdeletion Syndrome C6012360
No
14q12 Microdeletion Syndrome C4305240
No
Different transmission
Body System
2q13 Microdeletion Syndrome C6012360
congenital
14q12 Microdeletion Syndrome C4305240
congenital
Same/different system
Category
2q13 Microdeletion Syndrome C6012360
rare-disease
14q12 Microdeletion Syndrome C4305240
genetic
Different category
Bottom line
2q13-microdeletion-syndrome-C6012360 and 14q12-microdeletion-syndrome-C4305240 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2q13 Microdeletion Syndrome C6012360 | 14q12 Microdeletion Syndrome C4305240 | Discriminating power |
|---|---|---|---|
| Chromosomal locus | A small missing segment involving 2q13 | A missing segment involving 14q12 | High |
| Reported severity | Supplied severity label is severe | Supplied severity label is moderate | Moderate |
| Onset pattern | Onset is described as variable | Onset is listed as ages 0–1 | Moderate |
When to favor each condition
Choose 2q13 Microdeletion Syndrome C6012360 when
Testing confirms a 2q13 deletion
The chromosomal locus matches the left concept
High
Features begin outside infancy
Variable onset is the supplied left pattern, but timing alone is not diagnostic
Low
Care needs appear extensive
This only aligns with the severe label and requires clinical assessment
Low
Choose 14q12 Microdeletion Syndrome C4305240 when
Testing confirms a 14q12 deletion
The chromosomal locus matches the right concept
High
Concerns begin in the first year
This matches the supplied 0–1 onset but does not prove the diagnosis
Moderate
Course appears moderate
This matches only the supplied severity label
Low
How key tests differ
| Test | 2q13 Microdeletion Syndrome C6012360 | 14q12 Microdeletion Syndrome C4305240 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Deletion involving 2q13 | Deletion involving 14q12 | The reported locus is the main distinction; size and genes need specialist review. |
| Karyotype | A small deletion may be missed | A small deletion may be missed | A normal karyotype does not exclude either concept. |
| Parental genetic testing | May clarify inheritance | May clarify inheritance | Inheritance does not by itself establish severity or prognosis. |
Prognosis comparison
2q13 Microdeletion Syndrome C6012360
- Outcome
- Long-term outcome is not established; the source labels it severe and chronic.
- Factors
- Deletion extent, involved genes, and associated findings are unspecified.
14q12 Microdeletion Syndrome C4305240
- Outcome
- Outcome is not established; the source labels it moderate and chronic.
- Factors
- Segment details, developmental needs, and comorbidities are unspecified.
Time frame: Both are lifelong congenital conditions; precise milestones are unavailable.
Prognosis should be based on the genetic report and individual clinical findings.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental impact | Development can be affected Developmental delay may occur Specific developmental profiles are not established in the source. |
| Other clinical features | Distinctive features are possible Other health concerns are possible Organ-specific complications should not be assumed without evaluation. |
| Care burden | Multiple specialists may be needed Supportive, individualized care is described Both are chronic; exact service needs vary by person. |
Patient education highlights
- HighConfirmation
An abnormal or suspected finding is not a diagnosis until chromosomal testing is interpreted by a clinician.
- HighTransmission
Neither condition is communicable. Inheritance questions require genetic counseling.
- MediumCare
Management is supportive and symptom-based. No standard dose or treatment is established here.